Patents/Assignees

HEMOGENYX PHARMACEUTICALS LLC

1 patent in portfolio

US11945866utility2024
Method of Eliminating Hematopoietic Stem Cells/hematopoietic Progenitors (HSC/HP) in a Patient Using Bi-specific Antibodies
0 cites